Dr Reddy's Labs recalls muscle relaxant drug from US market

Last Updated: Thursday, April 11, 2013, 16:27

Dr Reddy's Laboratories has initiated recall of its tizanidine tablets, used as a muscle relaxant, from the US market due to labelling issues.

Dr Reddy's Lab to relocate its North America headquarters

Last Updated: Tuesday, April 9, 2013, 20:46

Drug major Dr Reddy's Laboratories Tuesday said it plans to relocate its North America headquarters to Princeton, New Jersey, and establish an R&D centre at the new location.

Dr Reddy's launches generic Zoledronic Acid injection in US

Last Updated: Thursday, April 4, 2013, 12:51

Zoledronic Acid injection is used for treating osteoporosis and Paget's disease of bone.

Dr Reddy's Lab appoints GV Prasad as Chairman

Last Updated: Monday, April 1, 2013, 18:17

Pharma company Dr Reddy's Laboratories Ltd Monday said it has appointed GV Prasad as Chairman and CEO, and Satish Reddy as Vice Chairman.

Dr Reddy's settle case with Nordion for $22.5 mn payment

Last Updated: Friday, March 22, 2013, 22:23

"The settlement was concluded on March 20, 2013, with the receipt of the settlement funds by Dr Reddy's," the drug major said in a statement.

Anji Reddy's absence not to change DRL's direction: Analysts

Last Updated: Sunday, March 17, 2013, 18:08

The demise of Anji Reddy, the founder-chairman of pharma major Dr Reddy's Laboratories, is not expected to lead to major directional changes, market analysts say.

Reddy Laboratories' founder chairman Anji Reddy dead

Last Updated: Saturday, March 16, 2013, 00:29

Kallam Anji Reddy, the founder chairman of Dr. Reddy's Laboratories, passed away Friday at a hospital here following brief illness. He was 73.

Dr Reddy's launches Zoledronic Acid Injection in US market

Last Updated: Tuesday, March 5, 2013, 16:03

The product is a generic version of Novartis Oncology's Zometa (zoledronic acid) injection in the same strength.

Nifty falls 10 points on earning woes, weak global sentiment

Last Updated: Friday, February 15, 2013, 21:03

Equities extended losses for the second day Friday as select heavyweights dragged the benchmark CNX Nifty down by 10 points on the National Stock Exchange.